We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
Cap. Flow
+$1.31B
Cap. Flow %
7.02%
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$109M
2
NCLH icon
Norwegian Cruise Line
NCLH
+$105M
3
GS icon
Goldman Sachs
GS
+$104M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$101M
5
STLD icon
Steel Dynamics
STLD
+$99.4M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$176M
2
KO icon
Coca-Cola
KO
+$151M
3
AVGO icon
Broadcom
AVGO
+$146M
4
MSFT icon
Microsoft
MSFT
+$140M
5
XOM icon
ExxonMobil
XOM
+$137M

Sector Composition

Rank Sector Weight
1 Technology 16.93%
2 Industrials 11.65%
3 Consumer Discretionary 11.56%
4 Healthcare 11.56%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVLV icon
851
Revolve Group
RVLV
$1.84B
$2.67M 0.01%
119,828
+109,790
+1,094% +$2.64M
PINC
852
DELISTED
Premier
PINC
$2.67M 0.01%
76,240
-287,417
-79% -$9.58M
TMHC icon
853
Taylor Morrison
TMHC
$2.66M 0.01%
87,661
+20,956
+31% +$584K
EWC icon
854
iShares MSCI Canada ETF
EWC
$6.13B
$2.65M 0.01%
80,853
+55,056
+213% +$1.82M
ACLS icon
855
Axcelis
ACLS
$3.94B
$2.64M 0.01%
33,222
-6,606
-17% -$465K
RVNC
856
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.62M 0.01%
141,880
+113,211
+395% +$2.59M
ABCL icon
857
AbCellera Biologics
ABCL
$1.6B
$2.62M 0.01%
258,517
+206,750
+399% +$2.39M
LAUR icon
858
Laureate Education
LAUR
$5.25B
$2.62M 0.01%
+271,875
New +$2.94M
ICFI icon
859
ICF International
ICFI
$1.45B
$2.61M 0.01%
+26,354
New +$2.87M
PEB icon
860
Pebblebrook Hotel Trust
PEB
$2.19B
$2.6M 0.01%
194,193
+167,065
+616% +$2.55M
SUI icon
861
Sun Communities
SUI
$15B
$2.59M 0.01%
18,132
-208,259
-92% -$28.4M
AXIA
862
AXIA Energia
AXIA
$22.9B
$2.59M 0.01%
412,601
-49,672
-11% -$338K
VCYT icon
863
Veracyte
VCYT
$4.44B
$2.58M 0.01%
108,772
-38,487
-26% -$894K
FMS icon
864
Fresenius Medical Care
FMS
$13.4B
$2.58M 0.01%
157,868
+4,094
+3% +$60.7K
TGTX icon
865
TG Therapeutics
TGTX
$8.53B
$2.55M 0.01%
215,527
+60,206
+39% +$437K
XM
866
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$2.54M 0.01%
244,609
+174,139
+247% +$1.82M
VMW
867
DELISTED
VMware, Inc
VMW
$2.53M 0.01%
20,642
-124,216
-86% -$14.3M
VIG icon
868
Vanguard Dividend Appreciation ETF
VIG
$112B
$2.53M 0.01%
16,687
+5,693
+52% +$848K
KT icon
869
KT
KT
$8.92B
$2.53M 0.01%
187,642
+28,241
+18% +$376K
BNY
870
Bank of New York Mellon
BNY
$107B
$2.53M 0.01%
55,521
-467,248
-89% -$20M
SWKS icon
871
Skyworks Solutions
SWKS
$9.54B
$2.51M 0.01%
27,529
-304,741
-92% -$27.3M
DVAX
872
DELISTED
Dynavax Technologies
DVAX
$2.51M 0.01%
+235,613
New +$2.74M
APLE icon
873
Apple Hospitality REIT
APLE
$3.98B
$2.49M 0.01%
158,056
+38,933
+33% +$628K
CNK icon
874
Cinemark Holdings
CNK
$3.93B
$2.49M 0.01%
+287,745
New +$3.24M
PARR icon
875
Par Pacific Holdings
PARR
$3.94B
$2.49M 0.01%
+106,936
New +$2.33M
33 34
35
36 37

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review

As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
  • Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
  • Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
  • Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
  • Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
  • Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.